Hemophagocytic lymphohistiocytosis (HLH) is traditionally regarded as a rapidly progressive and often fatal illness. In patients with AIDS, HLH usually occurs secondary to opportunistic infections. Although popular guidelines exist for the diagnosis and management of HLH in general, no formal study has evaluated their applicability among adult patients who develop HLH in the setting of AIDS and opportunistic infections. The study reports on a case of HLH in a patient with AIDS and disseminated histoplasmosis. Eighteen other previously reported cases of HLH in the setting of AIDS and histoplasmosis were reviewed. Majority of the cases occurred in patients with a CD4 count of less than 70 cells/mm(3). Overall mortality was 44%. Not getting antifungal treatment and having Histoplasma in blood were the 2 main risk factors for death. Among the patients who had a timely diagnosis of histoplasmosis and were initiated on antifungal therapy, the survival rates were significantly better, especially in the post-2000 ad period.

BackgroundMany countries with weaker health systems are struggling to put together a coherent strategy against the COVID-19 epidemic. We explored COVID-19 control strategies that could offer the greatest benefit in resource limited settings. MethodsUsing an age-structured SEIR model, we explored the effects of COVID-19 control interventions--a lockdown, physical distancing measures, and active case finding (testing and isolation, contact tracing and quarantine)--implemented individually and in combination to control a hypothetical COVID-19 epidemic in Kathmandu (population 2.6 million), Nepal. ResultsA month-long lockdown that is currently in place in Nepal will delay peak demand for hospital beds by 36 days, as compared to a base scenario of no interventions (peak demand at 108 days (Inter-Quartile Range IQR 97-119); a 2 month long lockdown will delay it by 74 days, without any difference in annual mortality, or healthcare demand volume. Year-long physical distancing measures will reduce peak demand to 36% (IQR 23%-46%) and annual morality to 67% (IQR 48%-77%) of base scenario. Following a month long lockdown with ongoing physical distancing measures and an active case finding intervention that detects 5% of the daily infection burden could reduce projected morality and peak demand by more than 99%. InterpretationLimited resources settings are best served by a combination of early and aggressive case finding with ongoing physical distancing measures to control the COVID-19 epidemic. A lockdown may be helpful until combination interventions can be put in place but is unlikely to reduce annual mortality or healthcare demand.

Primary HIV infection can occur in 40-90% of individuals recently infected with HIV. Variable symptoms usually suggestive of a flu-like illness as well as high-level HIV viraemia and steep decline in CD4 cell count are often noted. We report a case of a previously healthy homosexual man who presented with symptoms suspicious of primary HIV infection as well as non-productive cough associated with chest CT finding of diffuse ground glass appearance in lungs. Recent HIV seroconversion was confirmed. Diagnosis of Pneumocystis jirovecii pneumonia was made on transbronchial lung biopsy. The symptoms improved rapidly after initiation of treatment with trimethoprim-sulfamethoxazole. It is important to recognise that although Pneumocystis pneumonia is generally seen in the setting of AIDS, it can occasionally also occur during primary HIV infection.

Using natural plant extracts on metallic substances is the most frequently studied green corrosion inhibition approach in corrosion science. In this work, Coriaria nepalensis Stem Alkaloid (CNSA) has been successfully extracted and characterized by qualitative chemical (Mayer’s and Dragendroff’s) test and spectroscopic (UV and FTIR) measurement. CNSA has been employed as a green inhibitor for Mild Steel (MS) corrosion subjected to 1 M H2SO4 solution. The corrosion inhibition efficacy has been assessed by weight loss and polarization measurement methods. The effect of inhibitor concentration, immersion period, and temperature on the inhibition efficiency for the MS immersed in both acid and inhibitor solutions of different concentrations have been investigated. The maximum inhibition effect observed for CNSA is 96.4% for MS immersed in 1000 ppm inhibitor solution for 6 h at 18 °C by the weight loss measurement method. Similarly, the polarization measurement method observed a 97.03% inhibition efficiency for MS immersed for 3 h. The adsorption of inhibitor molecules on the MS surface aligns with the Langmuir model. The free energy of adsorption obtained is −28.75 kJ/mol indicating physical adsorption dominance over chemical adsorption. These findings suggested that CNSA has greater potential as an efficient green inhibitor.

Coronavirus Disease 2019 (COVID-19) burden is often underestimated when relying on case-based incidence reports. Seroprevalence studies accurately estimate infectious disease burden by estimating the population that has developed antibodies following an infection. Sero-Epidemiology of COVID-19 in the Kathmandu valley (SEVID-KaV) is a longitudinal survey of hospital-based health workers in the Kathmandu valley. Between December 3-25, we sampled 800 health workers from 20 hospitals and administered a questionnaire eliciting COVID-19 related history and tested for COVID-19 IgG antibodies. We then used a probabilistic multilevel regression model with post-stratification to correct for test accuracy, the effect of hospital-based clustering, and to establish representativeness. 522 (65.2%) of the participants were female, 372 (46%) were between ages 18-29, and 7 (0.9%) were 60 or above. 287 (36%) of the participants were nurses. About 23% of the participants previously had a PCR positive infection. 321 (40.13%) individuals tested positive for COVID-19 antibodies. Adjusted for test accuracy and weighted by age, gender and occupation category, the seroprevalence was 38.17% (95% Credible Interval (CrI) 29.26%–47.82%). Posterior predictive hospital-wise seroprevalence ranged between 38.1% (95% CrI 30.7.0%– 44.1%) and 40.5% (95% CrI 34.7%–47.0%).